Liberty All-Star Equity(USA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

USA Liberty All-Star Equity

Market Closed 03-28 16:00:00 EDT

6.54

-0.11

-1.65%

盘后6.54

+0.000.00%

18:35 EDT

High6.67	Low6.51	Vol775.10K
Open6.65	D1 Closing6.65	Amplitude2.36%
Mkt Cap1.89B	Tradable Cap0.00	Total Shares288.90M
T/O5.08M	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"USA","market":"US","secType":"STK","nameCN":"Liberty All-Star Equity","latestPrice":6.54,"timestamp":1743192000000,"preClose":6.65,"halted":0,"volume":775099,"hourTrading":{"tag":"盘后","latestPrice":6.54,"preClose":6.54,"latestTime":"18:35 EDT","volume":1909,"amount":12485.25,"timestamp":1743201313983},"delay":0,"floatShares":0,"shares":288899687,"eps":1.241353,"marketStatus":"Market Closed","change":-0.11,"latestTime":"03-28 16:00:00 EDT","open":6.65,"high":6.667,"low":6.51,"amount":5075752.078579,"amplitude":0.023609,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.241353,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743408000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":6.65,"dividendRate":0.108563,"preHourTrading":{"tag":"盘前","latestPrice":6.65,"preClose":6.65,"latestTime":"08:05 EDT","volume":461,"amount":3047.310037,"timestamp":1743163503960},"postHourTrading":{"tag":"盘后","latestPrice":6.54,"preClose":6.54,"latestTime":"18:35 EDT","volume":1909,"amount":12485.25,"timestamp":1743201313983},"volumeRatio":1.140324369594093},"requestUrl":"/m/hq/s/USA","defaultTab":"news","newsList":[{"id":"2523510631","title":"Electric Metals Partners with NAI Interactive to Expand Market Reach","url":"https://stock-news.laohu8.com/highlight/detail?id=2523510631","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523510631?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 05:39","pubTimestamp":1743197994,"startTime":"0","endTime":"0","summary":"The latest update is out from Nevada Silver ( ($TSE:EML) ). Electric Metals (USA) Limited has entered into a marketing agreement with NAI Interacti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/electric-metals-partners-with-nai-interactive-to-expand-market-reach?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/electric-metals-partners-with-nai-interactive-to-expand-market-reach?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USA"],"gpt_icon":0},{"id":"2522256217","title":"DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved","url":"https://stock-news.laohu8.com/highlight/detail?id=2522256217","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522256217?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 10:30","pubTimestamp":1743129000,"startTime":"0","endTime":"0","summary":"DBV Technologies Announces Financing of up to $306.9 Million  to Advance Viaskin Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved. DBV sufficiently funded through the expected Biologics License Application  submission to Food and Drug Administration  for the Viaskin peanut patch in children 4 – 7-years-old and commercial launch, if approved. “DBV is developing the Viaskin peanut patch for the treatment of pediatric peanut allergy. This injection of capital is coming on the heels of news issued earlier this week announcing alignment with the FDA on safety exposure data required for a BLA for Viaskin peanut patch in 4 – 7-year-olds, accelerating the timeline for a BLA filing submission upon potential successful completion of VITESSE,” said Daniel Tassé, Chief Executive Officer, DBV Technologies. “I wish to again thank the FDA for their engagement and quick response. We are thrilled that this significant transaction will support our tra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dbv-technologies-announces-financing-306-023000006.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DBVT","BK4156","DBVTF","BK4139","DBV","USA"],"gpt_icon":1},{"id":"2522534831","title":"Press Release: Heliogen, Inc. Announces Fourth Quarter and Full Year 2024 Financial and Operational Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522534831","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522534831?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 04:28","pubTimestamp":1743107280,"startTime":"0","endTime":"0","summary":"Heliogen, Inc.  , a renewable energy technology company utilizing concentrated sunlight and thermal energy storage to deliver dispatchable, cost-effective, low-carbon energy, today provided its fourth quarter and full year 2024 financial and operational results.-- Continued to prioritize the deployment of our commercially-proven power. solutions by taking actions to conserve cash and re-allocate resources. from activities that were no longer directly contributing to this goal.-- Together with Woodside Energy  Inc. , decided not. to pursue construction of a concentrated solar energy facility. that was designed to demonstrate at commercial scale our. next-generation thermal storage technology, to be built in Mojave,and commercially mature form of thermal energy storage technology,-- Concluded the targeted plan implemented in May 2024, which. included a workforce reduction, closing of the Long Beach. sequentially, compared to Q3 2024; and for full year 2024, reductions by. \"Reflecting on ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLGN","USA","BK4539","BK4096"],"gpt_icon":0},{"id":"2522340334","title":"Polyplex's US Arm Begins Commercial Production for Expansion Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2522340334","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522340334?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 17:19","pubTimestamp":1743067193,"startTime":"0","endTime":"0","summary":"Polyplex  said its step-down subsidiary Polyplex  has commenced commercial production after successful trial runs for a new BOPET thin film line and an expanded PET resin plant, according to an Indian bourse filing on Wednesday.The new thin film line adds 50,000 MT annual capacity, increasing total US capacity to 81,000 MT, while debottlenecking of the existing PET resin plant increased PET resin capacity to 86,000 MT from 58,000 MT.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0348723411.USD","IE00BMPRXR70.SGD","IE00BMPRXQ63.HKD","BK4141","BK4588","USA","BK4609","BK4543","IE00BMPRXN33.USD","BK4585"],"gpt_icon":1},{"id":"2522350642","title":"Ameren Missouri Announces Pricing of First Mortgage Bonds due 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2522350642","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522350642?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 07:04","pubTimestamp":1743030240,"startTime":"0","endTime":"0","summary":"ST. LOUIS, March 26, 2025 /PRNewswire/ -- Union Electric Company, doing business asAmeren Missouri, a subsidiary of Ameren Corporation , announced today the pricing of a public offering of $500 million aggregate principal amount of 5.25% first mortgage bonds due 2035 at 99.975% of their principal amount. The transaction is expected to close on April 4, 2025, subject to the satisfaction of customary closing conditions.Ameren Missouri intends to use the net proceeds of the offering to repay short-term debt and/or fund near-term capital expenditures.Goldman Sachs & Co. LLC, RBC Capital Markets, LLC, Scotia Capital  Inc., SMBC Nikko Securities America, Inc. and PNC Capital Markets LLC are acting as joint book-running managers for the offering.The offering is being made only by means of a prospectus and related prospectus supplement. A prospectus supplement related to the offering will be filed with the Securities and Exchange Commission. Copies of the prospectus and related prospectus supp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/ameren-missouri-announces-pricing-first-230400638.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ameren-missouri-announces-pricing-first-230400638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4606","AEE","BK4208","BK4588","USA","BK4585"],"gpt_icon":0},{"id":"2522887759","title":"Press Release: Americold Announces Pricing Terms for $400,000,000 Notes Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887759","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887759?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:10","pubTimestamp":1742933400,"startTime":"0","endTime":"0","summary":"ATLANTA, GA., March 25, 2025  -- Americold Realty Trust, Inc.  , a global leader in temperature-controlled logistics, real estate, and value-added services focused on the ownership, operation, acquisition and development of temperature-controlled warehouses, announced today that its operating partnership, Americold Realty Operating Partnership, L.P., a Delaware limited partnership , has priced an underwritten public offering of $400,000,000 of its 5.600% notes due May 15, 2032 . The Notes, which were priced at 99.862% of their principal amount to yield 5.622% to maturity, will be fully and unconditionally guaranteed jointly and severally , by each of the Company, Americold Realty Operations, Inc., a Delaware corporation and wholly-owned subsidiary of the Company and a limited partner of the Operating Partnership , and certain subsidiaries of the Operating Partnership . The offering is expected to close on April 3, 2025, subject to customary closing conditions.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","LU2357305700.SGD","LU1989772840.SGD","LU0795875169.SGD","LU0795875086.SGD","LU1548497426.USD","LU1989772923.USD","LU0320765646.SGD","LU0158827948.USD","LU2111349929.HKD","LU2347655156.SGD","BK4171","LU0225283273.USD","COLD","LU0006306889.USD","LU0912757837.SGD","LU1074936037.SGD","LU2089284900.SGD","LU0106831901.USD","LU0106261372.USD","BK4516","LU1363072403.SGD","BK4588","LU2028103732.USD","BK4127","CFA.SI","LU0098860793.USD","LU1720051017.SGD","BK4585","LU2089283258.USD","LU2271345857.HKD","BK4504","LU2023251221.USD","LU1720051108.HKD","LU2133065610.SGD","LU0314104364.USD","LU1162221912.USD","LU1732799900.SGD","USA","LU1732800096.USD","IE00BZ1G4Q59.USD","BK4581","LU0971096721.USD","LU1668664300.SGD","BK4534","LU0267386448.USD","BK4224","LU0158827781.USD"],"gpt_icon":0},{"id":"2522959880","title":"Humacyte, Inc. Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2522959880","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522959880?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:01","pubTimestamp":1742932860,"startTime":"0","endTime":"0","summary":"DURHAM, N.C., March 25, 2025  -- Humacyte, Inc. , a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has commenced an underwritten public offering of its common stock. In addition, Humacyte intends to grant the underwriters an option for a period of 30 days to purchase up to an additional 15% of the number of shares of common stock sold in connection with the offering. All of the shares are being offered by Humacyte.TD Cowen, Barclays and BTIG are acting as joint book-running managers for the offering. H.C. Wainwright & Co. and The Benchmark Company are acting as lead managers for the offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.Humacyte intends to use the net proceeds that it will receive from the offering to fund the commercialization of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humacyte-inc-announces-proposed-public-200100797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","HUMAW","HUMA","BK4563","USA"],"gpt_icon":0},{"id":"2522290022","title":"Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2522290022","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522290022?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 20:00","pubTimestamp":1742904000,"startTime":"0","endTime":"0","summary":"HAYWARD, Calif., March  25, 2025  (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/25/3048686/0/en/Benitec-Biopharma-Inc-Announces-Pricing-of-30-Million-Common-Stock-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BNTC","USA"],"gpt_icon":0},{"id":"2522502650","title":"O-I Glass Pioneers Sustainable Glassmaking with Successful Biofuel Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2522502650","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522502650?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 19:20","pubTimestamp":1742901600,"startTime":"0","endTime":"0","summary":"Achieved significant reduction in greenhouse gas emissions using 100% biofuel. Trial was part of the UK government's \"Net Zero Innovation Portfolio\" program. PERRYSBURG, Ohio /HARLOW, United Kingdom,, March 25, 2025  -- -- O-I Glass, Inc.  has recently successfully completed a groundbreaking trial in its plant in Harlow, UK, using 100% biofuel to replace natural gas in the furnace for the glass-making process. This achievement is part of a larger initiative led by Glass Futures, a UK-based glass R&D organization, and part of the UK government’s “Net Zero Innovation Portfolio” program, aimed at exploring sustainable fuel options for the industry in the UK.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/o-glass-pioneers-sustainable-glassmaking-112000498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OI","BK4126","USA"],"gpt_icon":0},{"id":"2522779087","title":"T-Mobile Agrees to Sell $3.5 Billion of Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2522779087","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522779087?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 07:45","pubTimestamp":1742859900,"startTime":"0","endTime":"0","summary":"BELLEVUE, Wash., March 24, 2025----T-Mobile US, Inc.   announced today that T-Mobile USA, Inc., its direct wholly-owned subsidiary , has agreed to sell $1,250,000,000 aggregate principal amount of its 5.125% Senior Notes due 2032 , $1,000,000,000 aggregate principal amount of its 5.300% Senior Notes due 2035  and $1,250,000,000 aggregate principal amount of its 5.875% Senior Notes due 2055  in a registered public offering.Barclays Capital Inc., Deutsche Bank Securities Inc., Morgan Stanley & Co. LLC, UBS Investment Bank, BNP Paribas Securities Corp., Citigroup Global Markets Inc., Commerz Markets LLC, Credit Agricole Securities  Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC, Santander US Capital Markets LLC, SG Americas Securities, LLC, SMBC Nikko Securities America, Inc., TD Securities  LLC, Truist Securities, Inc., U.S. Bancorp Investments, Inc. and Wells Fargo Securities, LLC are the join","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/t-mobile-agrees-sell-3-234500084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4581","IE00BMPRXN33.USD","LU2384288077.EUR","LU1303367103.USD","LU2247934214.USD","LU0708994859.HKD","BK4127","LU2028103732.USD","LU1267930573.SGD","LU0314104364.USD","LU0642271901.SGD","LU1668664300.SGD","TMUS","BK4534","LU0061474705.USD","LU0786609619.USD","LU2317271919.USD","LU2361045086.USD","LU0158827948.USD","BK4516","LU1066051225.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1506573853.SGD","LU0742534661.SGD","LU1074936037.SGD","LU1621767737.EUR","LU0251142724.SGD","LU0208291251.USD","LU1621768115.EUR","LU2210150020.SGD","LU0127658192.USD","BK4549","BK4585","IE00B3S45H60.SGD","LU1316542783.SGD","LU0048573561.USD","LU1989772923.USD","LU1720051017.SGD","LU1720051108.HKD","LU2361044949.HKD","LU0640476718.USD","LU2098885051.SGD","USA","IE00B775SV38.USD","LU1066053197.SGD","LU2271345857.HKD","LU0128525929.USD","LU0314106906.USD","LU0098860793.USD"],"gpt_icon":0},{"id":"2522086406","title":"Linde and O-I Partner to Install OPTIMELT® TCR Technology at Holzminden, Germany, Plant to Improve Efficiency and Reduce Emissions","url":"https://stock-news.laohu8.com/highlight/detail?id=2522086406","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522086406?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 04:20","pubTimestamp":1742847600,"startTime":"0","endTime":"0","summary":"Linde offers a broad range of technologies, including the patented OPTIMELTTM TCR technology, to help glass manufacturers increase the energy efficiency of their melting operations. This unique technology recovers waste heat from glass furnace flue gas to preheat and reform the natural gas feed. This decreases fuel consumption of the melting process by approximately 30% versus furnaces that do not feature this technology.The OPTIMELTTM TCR technology is also compatible with a range of fuels such as low carbon hydrogen or blends of hydrogen and natural gas. Linde’s OPTIMELTTM TCR technology is being implemented by glass manufacturing customers worldwide, including in the United States.At O-I Glass, Inc. , we love glass, and we are proud to be one of the leading producers of glass bottles and jars around the globe. Glass is not only beautiful, it is also pure, healthy, and completely recyclable, making it the most sustainable rigid packaging material. Headquartered in Perrysburg, Ohio , ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/linde-o-partner-install-optimelt-202000729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4126","USA","OI"],"gpt_icon":0},{"id":"2521466917","title":"EQT Announces Extension of Expiration Date for Exchange Offers and Consent Solicitations and Waiver of Consent Threshold Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2521466917","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521466917?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 18:30","pubTimestamp":1742812200,"startTime":"0","endTime":"0","summary":"PITTSBURGH, March 24, 2025 /PRNewswire/ --EQT Corporation   today announced the extension of the expiration date of the previously announced  offers by EQT to Eligible Holders  to exchange  any and all outstanding notes  issued by EQM Midstream Partners, LP , an indirect wholly owned subsidiary of EQT, for up to $4,541,839,000 aggregate principal amount of new notes to be issued by EQT  and cash and  related solicitation of consents  by EQM from Eligible Holders to adopt certain proposed amendments  to each of the indentures governing the Existing EQM Notes  that, if adopted, would eliminate substantially all of the restrictive covenants, certain events of default and certain other provisions currently contained in the Existing EQM Indentures.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/eqt-announces-extension-expiration-date-103000093.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eqt-announces-extension-expiration-date-103000093.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0006061336.USD","USA","LU1169589451.USD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU1169590202.USD","BK4213","BK4588","BK4585","IE00B19Z3B42.SGD","EQT","IE0002270589.USD"],"gpt_icon":0},{"id":"2521712152","title":"Polyplex's US Arm Begins Trial Runs for Expansion Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2521712152","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521712152?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 18:11","pubTimestamp":1742811113,"startTime":"0","endTime":"0","summary":"Polyplex , a step-down subsidiary of Polyplex  has started trial runs for a new BOPET thin film line and an expanded PET resin plant, according to an Indian bourse filing on Friday.The new thin film line adds 50,000 MT per annum capacity, bringing total US capacity to 81,000 MT while debottlenecking efforts have increased PET resin capacity to 86,000 MT from 58,000 MT, the filing said.Commercial production is set to begin in the coming days, the company said.The $124 million investment was funded through internal accruals and borrowings, according to the filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4543","USA","BK4585","BK4609","BK4588","IE00BMPRXR70.SGD","LU0348723411.USD","IE00BMPRXQ63.HKD","IE00BMPRXN33.USD","BK4141"],"gpt_icon":1},{"id":"2521425030","title":"Cosmo Pharmaceuticals publishes Annual Report 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2521425030","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521425030?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 14:13","pubTimestamp":1742537580,"startTime":"0","endTime":"0","summary":"Dublin, Ireland-- - Cosmo Pharmaceuticals N.V.    has published today its Annual Report for the fiscal year ending December 31, 2024. As already outlined in the unaudited 2024 Full-Year results on March 6, 2025, the reporting year was characterized by strong financial performance, exceptional revenue growth, significant strategic advancements, and a clear roadmap for future sustained corporate developments.The key highlights from Cosmo’s Annual Report 2024 include:. Detailed overview of the successes achieved in 2024. Statutory sections such as the Corporate Governance section and the Compensation Report. Giovanni Di Napoli, CEO of Cosmo, commented: “We are pleased to present Cosmo’s full Annual Report 2024 to our stakeholders today. This comes after we disclosed the unaudited results for 2024 two weeks ago. We now look forward to further interacting with investors, analysts and media professionals at our upcoming Investor Day, which will take place in Zurich on July 1.”April 2-3, 2025","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/cosmo-pharmaceuticals-publishes-annual-report-061300200.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cosmo-pharmaceuticals-publishes-annual-report-061300200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CMOPF","BK4007","USA"],"gpt_icon":0},{"id":"2521494099","title":"GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2521494099","media":"GlobeNewswire","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521494099?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 05:10","pubTimestamp":1742505000,"startTime":"0","endTime":"0","summary":"GENFIT completes a royalty financing of up to 185 million with HCRx after unanimous OCEANE bondholder approval, triggering a 130 million upfront payment with potential for an additional 55 million upon achieving near-term milestones. Non-dilutive financing extends cash runway beyond 2027 and supports GENFIT’s R&D efforts. Financing strengthens GENFIT's ACLF pipeline development and commitment to transformative therapies. GENFIT to use 61.66 million to repurchase 1,882,891 2025 OCEANEs after exercise by certain bondholders of their put option, reducing the nominal amount of GENFIT’s convertible debt to 586 thousand. Pascal Prigent, CEO of GENFIT, commented: “We are very pleased that we have now successfully closed this transaction. It gives us financial visibility beyond 2027 and will enable us to pursue development of all the programs in our very rich pipeline. We also believe it is positive for our shareholders as we have lifted our convertible debt burden without any dilution.”","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genfit-announces-completion-non-dilutive-211000503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GNFT","USA","CCA","GNFTF","BK4139","PBC"],"gpt_icon":0},{"id":"2521916764","title":"Tenon Medical Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2521916764","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521916764?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 04:05","pubTimestamp":1742501100,"startTime":"0","endTime":"0","summary":"~ Full Year 2024 Revenue of $3.3 Million, a 12% Increase Compared to Prior Year ~~ Interim Analysis from MAINSAIL Study Reinforces Safety Profile, Effectiveness and Confirmation of Fusion ~~ Catamaran SI Joint Fusion Technology Protected with Robust Patent Portfolio of Twelve U.S. and International Patents ~~ Introduced Catamaran SE Platform and Successfully Completed Initial Clinical Procedures ~~ National Commercial Launch of Catamaran SE in Mid-2025 ~LOS GATOS, CA / ACCESS Newswire / March 20, 2025 / Tenon Medical, Inc.  , a company transforming care for patients suffering from certain Sacroiliac Joint  disorders, today reported financial results for the fourth quarter and year ended December 31, 2024.Revenue of $3.3 million, a 12% increase compared to $2.9 million in 2023.Gross profit of $1.7 million, a 38% increase compared to $1.2 million in 2023.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tenon-medical-reports-fourth-quarter-200500198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SIJ","BK4082","USA","TNONW","TNON"],"gpt_icon":0},{"id":"2520715193","title":"Orchid Island Capital Announces March 2025 Monthly Dividend and February 28, 2025 RMBS Portfolio Characteristics","url":"https://stock-news.laohu8.com/highlight/detail?id=2520715193","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520715193?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 04:10","pubTimestamp":1742415000,"startTime":"0","endTime":"0","summary":"March 2025 Monthly Dividend of $0.12 Per Share of Common Stock. RMBS Portfolio Characteristics as of February 28, 2025. VERO BEACH, Fla., March 19, 2025  -- Orchid Island Capital, Inc.   announced today that the Board of Directors of the Company declared a monthly cash dividend for the month of March 2025. The dividend of $0.12per share will be paid April 29, 2025to holders of record of the Company’s common stock on March 31, 2025, with an ex-dividend date of March 31, 2025. The Company plans on announcing its next common stock dividend on April 9, 2025.This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. These forward-looking statements include, but are not limited to, statements about the Company’s distr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/orchid-island-capital-announces-march-201000735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ORC","RMBS","USA","BK4141","IE00BLSP4239.USD","BK4110","US10Y.BOND","US2Y.BOND","US30Y.BOND","US6M.BOND","IE00BBT3K403.USD","US12M.BOND","US3Y.BOND","BK4585","US5Y.BOND","IE00BN8TJ469.HKD","US7Y.BOND"],"gpt_icon":0},{"id":"2520169682","title":"Celanese Announces Pricing of Cash Tender Offers for 4.777% Senior Notes due 2026 and 6.415% Senior Notes due 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2520169682","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520169682?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 02:12","pubTimestamp":1742407920,"startTime":"0","endTime":"0","summary":"DALLAS, March 19, 2025 /PRNewswire/ -- Celanese Corporation  , a global chemical and specialty materials company, today announced the pricing of offers by its direct wholly-owned subsidiary Celanese US Holdings LLC  to purchase for cash any validly tendered  and accepted notes in an aggregate principal amount equal to  552,082,000 of 4.777% Senior Notes due 2026  and  $500,000,000 of 6.415% Senior Notes due 2027  as described in the table below .The Tender Offers have been made upon the terms and subject to the conditions set forth in the Offer to Purchase, dated March 5, 2025, as amended and supplemented by the press release dated March 18, 2025 . Capitalized terms not defined in this announcement have the meanings given to them in the Offer to Purchase.The following table indicates, among other things, the principal amount of Notes validly tendered  that will be accepted for purchase:. The Tender Offers are subject to a Series Cap equal to 552,082,000 aggregate princi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/celanese-announces-pricing-cash-tender-181200614.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/celanese-announces-pricing-cash-tender-181200614.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","USA","BK4588","BK4544","BK4156","CE","BK4585","ARKG"],"gpt_icon":0},{"id":"2520513307","title":"Press Release: Jacobio Pharma Announces 2024 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520513307","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520513307?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 21:42","pubTimestamp":1742391720,"startTime":"0","endTime":"0","summary":"BEIJING, SHANGHAI and BOSTON, March 19, 2025 /PRNewswire/ -- Jacobio Pharma  released its 2024 annual results, with revenue of RMB160 million, R&D expense of RMB330 million. Major operating and financing activities generated RMB320 million cash inflows. By the end of 2024, cash and bank balances and bank credit balances amounted to RMB1.45 billion. Jacobio also announced recent business progress and expected milestones.\"2024 is a transforatmive year for Jacobio. We have submitted a New Drug Application  for the KRAS G12C inhibitor glecirasib and have licensed out the China rights of glecirasib and the SHP2 inhibitor sitneprotafib to our partner. This marks  Jacobio's  successful transformation  from the early R&D stage to an innovation-driven value realization stage,\" said Dr.Yinxiang Wang, the Chairman and CEO of Jacobio Pharma. \"Looking ahead to 2025, glecirasib is expected to receive the official approval for marking, which will continuously generate cash flow to invest in Jacobio' ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","01167","BK1161","ODD","BK1574","USA"],"gpt_icon":0},{"id":"2520185087","title":"Herc Holdings Commences Tender Offer for All Outstanding Shares of H&E Equipment Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2520185087","media":"Business Wire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520185087?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:30","pubTimestamp":1742383800,"startTime":"0","endTime":"0","summary":"H&E Shareholders to Receive $78.75 in Cash and 0.1287 shares of Herc Common Stock Per H&E Share. The Offer will expire at one minute past 11:59 p.m. Eastern Time, on April 15, 2025, unless extended or earlier terminated, in each case in accordance with the terms of the merger agreement. The Offer is subject to the majority of H&E’s shares being tendered into the Offer, the receipt of customary regulatory approvals and other customary closing conditions. Herc will finance the Offer through a combination of available cash on hand, proceeds from the sale of marketable securities and funds drawn through its credit facility, which was amended on March 11, 2025, in connection with the H&E transaction. Following completion of the Offer, Herc will acquire all remaining shares not tendered in the Offer through a second-step merger at the same price as in the Offer. The transaction is expected to close mid-year 2025.Founded in 1965, Herc Holdings Inc., which operates through its Herc Rentals Inc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/herc-holdings-commences-tender-offer-113000717.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","HEES","HRI","BK4104","BK4544","ARKG","IE00B66KJ199.SGD","BK4588","IE0031619046.USD","USA","IE00B7SZL793.SGD","IE00B19Z4B17.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.all-starfunds.com","stockEarnings":[{"period":"1week","weight":-0.0151},{"period":"1month","weight":-0.0549},{"period":"3month","weight":-0.0657},{"period":"6month","weight":-0.0789},{"period":"1year","weight":-0.0853},{"period":"ytd","weight":-0.059}],"compareEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0654},{"period":"3month","weight":-0.0661},{"period":"6month","weight":-0.0277},{"period":"1year","weight":0.0623},{"period":"ytd","weight":-0.0519}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Liberty All Star Equity Fund is a closed-ended equity mutual fund launched and managed by ALPS Advisers, Inc. The fund is co-managed by Aristotle Capital Management, LLC, Pzena Investment Management, LLC, Delaware Investments Fund Advisers, Sustainable Growth Advisers, LP, and TCW Investment Management Company. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in value and growth stocks of large cap companies. The fund benchmarks the performance of its portfolio against the Lipper Large-Cap Core Mutual Fund Average, the Dow Jones Industrial Average, the NASDAQ Composite Index, and the S&P 500 Index. Liberty All Star Equity Fund was formed on October 31, 1986 and is domiciled in the United States.","yearOnYearQuotes":[{"month":1,"riseRate":0.564103,"avgChangeRate":0.011833},{"month":2,"riseRate":0.487179,"avgChangeRate":0.000057},{"month":3,"riseRate":0.564103,"avgChangeRate":0.002693},{"month":4,"riseRate":0.552632,"avgChangeRate":0.01072},{"month":5,"riseRate":0.526316,"avgChangeRate":-0.005343},{"month":6,"riseRate":0.526316,"avgChangeRate":0.005034},{"month":7,"riseRate":0.552632,"avgChangeRate":0.009349},{"month":8,"riseRate":0.394737,"avgChangeRate":-0.021652},{"month":9,"riseRate":0.473684,"avgChangeRate":-0.008417},{"month":10,"riseRate":0.5,"avgChangeRate":-0.003081},{"month":11,"riseRate":0.615385,"avgChangeRate":-0.000694},{"month":12,"riseRate":0.615385,"avgChangeRate":0.006997}],"exchange":"NYSE","name":"Liberty All-Star Equity","nameEN":"Liberty All-Star Equity"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liberty All-Star Equity(USA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Liberty All-Star Equity(USA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Liberty All-Star Equity,USA,Liberty All-Star Equity股票,Liberty All-Star Equity股票老虎,Liberty All-Star Equity股票老虎国际,Liberty All-Star Equity行情,Liberty All-Star Equity股票行情,Liberty All-Star Equity股价,Liberty All-Star Equity股市,Liberty All-Star Equity股票价格,Liberty All-Star Equity股票交易,Liberty All-Star Equity股票购买,Liberty All-Star Equity股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liberty All-Star Equity(USA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Liberty All-Star Equity(USA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction